サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1594963

着床前遺伝学的検査の世界市場

Preimplantation Genetic Testing

出版日
ページ情報
英文 89 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
着床前遺伝学的検査の世界市場
出版日: 2024年11月22日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 89 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

着床前遺伝学的検査の世界市場は2030年までに15億米ドルに到達

2023年に7億6,800万米ドルと推定される着床前遺伝学的検査の世界市場は、分析期間2023-2030年にCAGR 9.9%で成長し、2030年には15億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである試薬・消耗品コンポーネントは、CAGR 10.6％を記録し、分析期間終了時には7億9,410万米ドルに達すると予測されます。機器部門の成長率は、分析期間中CAGR 8.9％と推定されます。

米国市場は2億1,250万米ドルと推定、中国はCAGR 9.3％で成長予測

米国の着床前遺伝学的検査市場は、2023年に2億1,250万米ドルと推定されます。世界第2位の経済大国である中国は、2023年から2030年の分析期間においてCAGR 9.3%で推移し、2030年には予測市場規模2億2,690万米ドルに達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ9.3％と8.1％と予測されています。欧州では、ドイツがCAGR約8.1%で成長すると予測されています。

世界の着床前遺伝学的検査市場- 主要動向と促進要因まとめ

生殖補助医療技術の需要増加は着床前遺伝学的検査市場をどのように形成しているか？

着床前遺伝学的検査（PGT）市場は、体外受精（IVF）などの生殖補助医療技術（ART）の需要増が主な要因となって、大きく成長しつつあります。世界的に不妊率が上昇するにつれて、妊娠を達成するために高度な生殖オプションを求めるカップルが増え、PGTの利用率の上昇につながっています。この検査は、着床前に胚の特定の遺伝的状態をスクリーニングすることを可能にし、それによって妊娠成功の可能性を高め、遺伝性疾患のリスクを低減します。体外受精の手順にPGTを組み込むことは標準的な慣行となり、ARTを受けるカップルの意思決定プロセスに大きな影響を与えています。遺伝子検査技術の進歩に伴い、PGTは、染色体異常、単一遺伝子障害、異数性を含む幅広い遺伝子疾患に対して、より正確で包括的なスクリーニングを提供できるように進化してきました。

さらに、一般集団における遺伝子検査に対する認識と受容の高まりが、PGT市場の成長に寄与しています。教育キャンペーンや遺伝子検査の利点に関する情報の入手が可能になったことで、これから親になろうとする人たちが、生殖の健康について十分な情報を得た上で決断を下すことができるようになった。この動向は、母親の年齢が高いために子供の遺伝的健康についてより心配する可能性のある高齢の両親の間で特に顕著です。PGTの需要は、このようなサービスを提供する不妊治療クリニックの数が増加していることで、以前は選択肢を知らなかったかもしれないカップルにとってPGTがより身近なものとなっていることも後押ししています。遺伝子検査に対する消費者の信頼が高まるにつれて、着床前遺伝学的検査の市場も拡大しています。

技術の進歩が着床前遺伝学的検査の進化に果たす役割とは？

技術の進歩は、より正確で効率的な検査法を可能にし、PGTの状況を変える上で重要な役割を果たしています。次世代シークエンシング（NGS）技術のイントロダクションは遺伝子検査に革命をもたらし、より高い精度とスピードで複数の遺伝子や染色体を同時に解析することを可能にしました。NGSは包括的な着床前遺伝子診断（PGD）と着床前遺伝子スクリーニング（PGS）を容易にし、臨床医が胚の遺伝子異常をより効果的に特定することを可能にします。この技術は、遺伝子異常の検出率を高めるだけでなく、検査に必要な時間を短縮するものであり、体外受精サイクルにおける胚選択という時間的制約のある状況においては極めて重要です。

さらに、胚培養技術の進歩やタイムラプスイメージング技術の開発により、胚の評価が向上し、胚培養士が胚の発育をリアルタイムでモニターできるようになった。これらの技術革新は、生存可能な胚のより良い選択を可能にするため、着床と妊娠の成功の可能性を最適化します。技術が進化し続けるにつれて、PGTは検査室のワークフローを強化し、人的ミスを減らす自動化システムとますます統合されるようになると予想されます。この統合により、遺伝子検査のプロセスはさらに合理化され、患者にとってより効率的で利用しやすいものになるでしょう。

消費者の嗜好の変化は着床前遺伝学的検査市場にどのような影響を与えているか？

個別化ヘルスケアに対する消費者の嗜好の変化は、PGTサービスの需要に大きな影響を与えています。遺伝的健康に対する意識が高まるにつれ、個人やカップルは個人の健康目標や生殖計画に沿った選択肢を求める傾向が強くなっています。個別化医療の動向は遺伝子検査の受け入れ拡大につながり、消費者はPGTを遺伝性疾患の予防措置としてだけでなく、生殖の選択を調整する手段としてもとらえています。この変化は、健康とウェルネスを優先し、遺伝的健康の管理に積極的なミレニアル世代とZ世代の消費者に特に顕著です。

加えて、家族計画に対する願望や、若い世代における子作りの遅れという傾向の高まりが、PGTに対する需要をさらに押し上げています。個人がキャリアと個人の成長を優先させるにつれて、染色体異常を含む母親の高年齢化に伴うリスクを軽減するのに役立つ生殖技術を求めることが多いです。この動向により、遺伝子検査は不妊治療の日常的な一部として受け入れられつつあり、多くの親候補者はPGTを体外受精のプロセスにおける不可欠なステップと考えています。その結果、不妊治療クリニックは、患者の進化する期待に応えるため、サービスの標準的な要素としてPGTを提供するようになってきています。

着床前遺伝学的検査市場の成長を促進する要因は何か？

着床前遺伝学的検査（PGT）市場の成長は、遺伝子検査技術の進歩、不妊率の増加、遺伝的健康に対する消費者の意識の高まりなど、いくつかの要因によって牽引されています。次世代シークエンシング（NGS）やその他の革新的技術の進化により、PGTの精度と効率は大幅に向上し、生殖補助医療を受ける多くの親候補にとって好ましい選択肢となっています。さらに、不妊症の蔓延とARTソリューションへの需要の高まりにより、妊娠成功の可能性を高めようとするカップルが増え、PGTの対応可能市場が拡大しています。

さらに、個別化された健康とウェルネスに対する消費者行動の変化が、PGTの採用拡大に寄与しています。より多くの個人が自分の遺伝的健康の選択肢について知るようになるにつれて、特定の健康目標に沿ったオーダーメイドの生殖サービスに対する期待が高まっています。PGTの標準的な体外受精への統合は、これらのサービスを提供する不妊治療クリニックの増加によってさらに促進され、より幅広い人々にとってよりアクセスしやすくなっています。遺伝子検査に対する規制上の支援とヘルスケア政策の進歩も、PGTの採用を促進する上で重要な役割を果たしています。これらの要因が相まって、着床前遺伝学的検査市場は力強い成長環境を生み出し、現代のリプロダクティブ・ヘルスケアの重要な要素として位置づけられています。

セグメント

コンポーネント（試薬＆消耗品、機器、ソフトウェア＆サービス）、テクノロジー（次世代シーケンシング（NGS）、ポリメラーゼ連鎖反応（PCR）、蛍光in-situハイブリダイゼーション（FISH）、その他のテクノロジー）、エンドユーザー（産科センター＆不妊治療クリニック、病院、診断ラボ＆サービスプロバイダー、研究所＆学術機関）

調査対象企業の例（合計 34注目）

  • Ariosa Diagnostics
  • Bioarray S.L.
  • California Pacific Medical Center（CPMC）
  • CombiMatrix
  • CooperSurgical, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Genea Limited
  • Genesis Genetics
  • Good Start Genetics, Inc.
  • IGENOMIX
  • Illumina, Inc.
  • Invitae Corporation
  • Laboratory Corporation of America Holdings
  • Natera, Inc.
  • Oxford Gene Technology
  • PerkinElmer Inc.
  • Quest Diagnostics Incorporated
  • Reproductive Genetic Innovations, LLC
  • Reprogenetics
  • RHS Ltd.
  • Sequenom
  • Thermo Fisher Scientific, Inc.

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

第4章 競合

目次
Product Code: MCP22620

Global Preimplantation Genetic Testing Market to Reach US$1.5 Billion by 2030

The global market for Preimplantation Genetic Testing estimated at US$768.0 Million in the year 2023, is expected to reach US$1.5 Billion by 2030, growing at a CAGR of 9.9% over the analysis period 2023-2030. Reagents & Consumables Component, one of the segments analyzed in the report, is expected to record a 10.6% CAGR and reach US$794.1 Million by the end of the analysis period. Growth in the Instruments Component segment is estimated at 8.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$212.5 Million While China is Forecast to Grow at 9.3% CAGR

The Preimplantation Genetic Testing market in the U.S. is estimated at US$212.5 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$226.9 Million by the year 2030 trailing a CAGR of 9.3% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 9.3% and 8.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 8.1% CAGR.

Global Preimplantation Genetic Testing Market – Key Trends & Drivers Summarized

How Is the Rising Demand for Assisted Reproductive Technologies Shaping the Preimplantation Genetic Testing Market?

The preimplantation genetic testing (PGT) market is undergoing significant growth, largely driven by the increasing demand for assisted reproductive technologies (ART) such as in vitro fertilization (IVF). As infertility rates rise globally, more couples are seeking advanced reproductive options to achieve pregnancy, leading to an uptick in the utilization of PGT. This testing allows for the screening of embryos for specific genetic conditions before implantation, thereby enhancing the chances of a successful pregnancy and reducing the risk of genetic disorders. The integration of PGT into IVF procedures has become a standard practice, significantly influencing the decision-making process for couples undergoing ART. With the advancements in genetic testing technologies, PGT has evolved to offer more accurate and comprehensive screening for a wide range of genetic disorders, including chromosomal abnormalities, single-gene disorders, and aneuploidies.

Moreover, the increasing awareness and acceptance of genetic testing in the general population are contributing to the growth of the PGT market. Educational campaigns and the availability of information regarding the benefits of genetic testing have empowered prospective parents to make informed decisions about their reproductive health. This trend is particularly pronounced among older parents who may be more concerned about the genetic health of their children due to advanced maternal age. The demand for PGT is also fueled by the increasing number of fertility clinics offering these services, making PGT more accessible to couples who may have previously been unaware of their options. As consumer confidence in genetic testing grows, so does the market for preimplantation genetic testing.

What Role Do Technological Advancements Play in the Evolution of Preimplantation Genetic Testing?

Technological advancements are playing a crucial role in transforming the PGT landscape, enabling more precise and efficient testing methods. The introduction of next-generation sequencing (NGS) technologies has revolutionized genetic testing, allowing for the simultaneous analysis of multiple genes and chromosomes with greater accuracy and speed. NGS facilitates comprehensive preimplantation genetic diagnosis (PGD) and preimplantation genetic screening (PGS), enabling clinicians to identify genetic abnormalities in embryos more effectively. This technology not only enhances the detection rates of genetic disorders but also reduces the time required for testing, which is critical in the time-sensitive context of embryo selection during IVF cycles.

Furthermore, advancements in embryo culture techniques and the development of time-lapse imaging technologies have improved embryo assessment, enabling embryologists to monitor embryo development in real time. These innovations allow for better selection of viable embryos, thus optimizing the chances of successful implantation and pregnancy. As the technology continues to evolve, it is anticipated that PGT will become increasingly integrated with automated systems that enhance laboratory workflows and reduce human error. This integration will further streamline the process of genetic testing, making it more efficient and accessible for patients.

How Are Changing Consumer Preferences Influencing the Preimplantation Genetic Testing Market?

Changing consumer preferences towards personalized healthcare are significantly influencing the demand for PGT services. As awareness about genetic health increases, individuals and couples are more inclined to seek options that align with their personal health goals and reproductive plans. The trend towards personalized medicine has led to a greater acceptance of genetic testing, as consumers view PGT not only as a preventive measure against hereditary diseases but also as a means to tailor their reproductive choices. This shift is particularly evident among millennials and Gen Z consumers, who prioritize health and wellness and are proactive about managing their genetic health.

Additionally, the desire for family planning and the growing trend of delayed parenthood among younger generations further drive the demand for PGT. As individuals prioritize career and personal development, they often seek reproductive technologies that can help mitigate the risks associated with advanced maternal age, including chromosomal abnormalities. This trend has led to a growing acceptance of genetic testing as a routine part of the fertility journey, with many prospective parents considering PGT an essential step in the IVF process. As a result, fertility clinics are increasingly offering PGT as a standard component of their services to meet the evolving expectations of their patients.

What Factors Are Driving Growth in the Preimplantation Genetic Testing Market?

The growth in the preimplantation genetic testing (PGT) market is driven by several factors, including advancements in genetic testing technologies, increasing infertility rates, and rising consumer awareness of genetic health. The evolution of next-generation sequencing (NGS) and other innovative technologies has significantly improved the accuracy and efficiency of PGT, making it a preferred choice for many prospective parents undergoing assisted reproductive technologies. Additionally, the growing prevalence of infertility and the demand for ART solutions have expanded the addressable market for PGT, as couples seek to enhance their chances of a successful pregnancy.

Moreover, changing consumer behaviors towards personalized health and wellness are contributing to the increased adoption of PGT. As more individuals become informed about their genetic health options, there is a rising expectation for tailored reproductive services that align with their specific health goals. The integration of PGT into standard IVF practices is further fueled by the increasing number of fertility clinics offering these services, making them more accessible to a broader population. Regulatory support for genetic testing and advancements in healthcare policies also play a significant role in promoting the adoption of PGT. Together, these factors create a robust growth environment for the preimplantation genetic testing market, positioning it as a critical component of modern reproductive health care.

SCOPE OF STUDY:

The report analyzes the Preimplantation Genetic Testing market in terms of US$ Thousand by the following Component; End-Use; Technology, and Geographic Regions/Countries:

Segments:

Component (Reagents & Consumables, Instruments, Software & Services); Technology (Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH), Other Technologies); End-Use (Maternity Centers & Fertility Clinics, Hospitals, Diagnostic Labs & Service Providers, Research Laboratories & Academic Institutes)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 34 Featured) -

  • Ariosa Diagnostics
  • Bioarray S.L.
  • California Pacific Medical Center (CPMC)
  • CombiMatrix
  • CooperSurgical, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Genea Limited
  • Genesis Genetics
  • Good Start Genetics, Inc.
  • IGENOMIX
  • Illumina, Inc.
  • Invitae Corporation
  • Laboratory Corporation of America Holdings
  • Natera, Inc.
  • Oxford Gene Technology
  • PerkinElmer Inc.
  • Quest Diagnostics Incorporated
  • Reproductive Genetic Innovations, LLC
  • Reprogenetics
  • RHS Ltd.
  • Sequenom
  • Thermo Fisher Scientific, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Preimplantation Genetic Testing - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for Assisted Reproductive Technologies (ART) Drives Adoption of Preimplantation Genetic Testing (PGT)
    • Increasing Awareness of Genetic Disorders Expands the Addressable Market for Preimplantation Genetic Testing
    • Advancements in Next-Generation Sequencing (NGS) Propel Growth in Preimplantation Genetic Testing for Enhanced Accuracy
    • Growing Focus on Improving In Vitro Fertilization (IVF) Success Rates Strengthens the Business Case for Preimplantation Genetic Testing
    • Increasing Incidence of Genetic Disorders and Chromosomal Abnormalities Spurs Demand for PGT in Fertility Treatments
    • Technological Advancements in Embryo Biopsy Techniques Expand Opportunities for Preimplantation Genetic Testing
    • Rising Adoption of Non-Invasive Genetic Testing Methods Drives Innovation in Preimplantation Genetic Testing
    • Growing Trend Toward Delayed Parenthood Expands Demand for Preimplantation Genetic Testing in Older Patients
    • Increasing Focus on Personalized Medicine in Reproductive Health Expands the Use of Preimplantation Genetic Testing
    • Rising Consumer Demand for Family Planning Solutions Propels Growth in Preimplantation Genetic Testing Market
    • Growing Use of Preimplantation Genetic Testing for Gender Selection Creates New Market Opportunities
    • Expanding Use of Preimplantation Genetic Testing in Detecting Single-Gene Disorders Strengthens Market Growth
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Preimplantation Genetic Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Preimplantation Genetic Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Preimplantation Genetic Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Reagents & Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Reagents & Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Reagents & Consumables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Software & Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Software & Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Software & Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Research Laboratories & Academic Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Research Laboratories & Academic Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 15: World 16-Year Perspective for Research Laboratories & Academic Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Maternity Centers & Fertility Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Maternity Centers & Fertility Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 18: World 16-Year Perspective for Maternity Centers & Fertility Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Hospitals, Diagnostic Labs & Service Providers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Hospitals, Diagnostic Labs & Service Providers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 21: World 16-Year Perspective for Hospitals, Diagnostic Labs & Service Providers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Next Generation Sequencing (NGS) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Next Generation Sequencing (NGS) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 24: World 16-Year Perspective for Next Generation Sequencing (NGS) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 25: World Recent Past, Current & Future Analysis for Polymerase Chain Reaction (PCR) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 26: World Historic Review for Polymerase Chain Reaction (PCR) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 27: World 16-Year Perspective for Polymerase Chain Reaction (PCR) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for Fluorescent In-Situ Hybridization (FISH) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 29: World Historic Review for Fluorescent In-Situ Hybridization (FISH) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 30: World 16-Year Perspective for Fluorescent In-Situ Hybridization (FISH) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 31: World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 32: World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 33: World 16-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 34: World Preimplantation Genetic Testing Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Preimplantation Genetic Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 35: USA Recent Past, Current & Future Analysis for Preimplantation Genetic Testing by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Preimplantation Genetic Testing by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 37: USA 16-Year Perspective for Preimplantation Genetic Testing by Component - Percentage Breakdown of Value Sales for Reagents & Consumables, Instruments and Software & Services for the Years 2014, 2024 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Preimplantation Genetic Testing by End-Use - Research Laboratories & Academic Institutes, Maternity Centers & Fertility Clinics and Hospitals, Diagnostic Labs & Service Providers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Preimplantation Genetic Testing by End-Use - Research Laboratories & Academic Institutes, Maternity Centers & Fertility Clinics and Hospitals, Diagnostic Labs & Service Providers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 40: USA 16-Year Perspective for Preimplantation Genetic Testing by End-Use - Percentage Breakdown of Value Sales for Research Laboratories & Academic Institutes, Maternity Centers & Fertility Clinics and Hospitals, Diagnostic Labs & Service Providers for the Years 2014, 2024 & 2030
    • TABLE 41: USA Recent Past, Current & Future Analysis for Preimplantation Genetic Testing by Technology - Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Preimplantation Genetic Testing by Technology - Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: USA 16-Year Perspective for Preimplantation Genetic Testing by Technology - Percentage Breakdown of Value Sales for Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and Other Technologies for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Preimplantation Genetic Testing by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Preimplantation Genetic Testing by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 46: Canada 16-Year Perspective for Preimplantation Genetic Testing by Component - Percentage Breakdown of Value Sales for Reagents & Consumables, Instruments and Software & Services for the Years 2014, 2024 & 2030
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Preimplantation Genetic Testing by End-Use - Research Laboratories & Academic Institutes, Maternity Centers & Fertility Clinics and Hospitals, Diagnostic Labs & Service Providers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Preimplantation Genetic Testing by End-Use - Research Laboratories & Academic Institutes, Maternity Centers & Fertility Clinics and Hospitals, Diagnostic Labs & Service Providers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 49: Canada 16-Year Perspective for Preimplantation Genetic Testing by End-Use - Percentage Breakdown of Value Sales for Research Laboratories & Academic Institutes, Maternity Centers & Fertility Clinics and Hospitals, Diagnostic Labs & Service Providers for the Years 2014, 2024 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Preimplantation Genetic Testing by Technology - Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Preimplantation Genetic Testing by Technology - Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 52: Canada 16-Year Perspective for Preimplantation Genetic Testing by Technology - Percentage Breakdown of Value Sales for Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and Other Technologies for the Years 2014, 2024 & 2030
  • JAPAN
    • Preimplantation Genetic Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Preimplantation Genetic Testing by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Preimplantation Genetic Testing by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 55: Japan 16-Year Perspective for Preimplantation Genetic Testing by Component - Percentage Breakdown of Value Sales for Reagents & Consumables, Instruments and Software & Services for the Years 2014, 2024 & 2030
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Preimplantation Genetic Testing by End-Use - Research Laboratories & Academic Institutes, Maternity Centers & Fertility Clinics and Hospitals, Diagnostic Labs & Service Providers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Preimplantation Genetic Testing by End-Use - Research Laboratories & Academic Institutes, Maternity Centers & Fertility Clinics and Hospitals, Diagnostic Labs & Service Providers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 58: Japan 16-Year Perspective for Preimplantation Genetic Testing by End-Use - Percentage Breakdown of Value Sales for Research Laboratories & Academic Institutes, Maternity Centers & Fertility Clinics and Hospitals, Diagnostic Labs & Service Providers for the Years 2014, 2024 & 2030
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Preimplantation Genetic Testing by Technology - Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Preimplantation Genetic Testing by Technology - Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 61: Japan 16-Year Perspective for Preimplantation Genetic Testing by Technology - Percentage Breakdown of Value Sales for Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and Other Technologies for the Years 2014, 2024 & 2030
  • CHINA
    • Preimplantation Genetic Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 62: China Recent Past, Current & Future Analysis for Preimplantation Genetic Testing by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Preimplantation Genetic Testing by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 64: China 16-Year Perspective for Preimplantation Genetic Testing by Component - Percentage Breakdown of Value Sales for Reagents & Consumables, Instruments and Software & Services for the Years 2014, 2024 & 2030
    • TABLE 65: China Recent Past, Current & Future Analysis for Preimplantation Genetic Testing by End-Use - Research Laboratories & Academic Institutes, Maternity Centers & Fertility Clinics and Hospitals, Diagnostic Labs & Service Providers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Preimplantation Genetic Testing by End-Use - Research Laboratories & Academic Institutes, Maternity Centers & Fertility Clinics and Hospitals, Diagnostic Labs & Service Providers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 67: China 16-Year Perspective for Preimplantation Genetic Testing by End-Use - Percentage Breakdown of Value Sales for Research Laboratories & Academic Institutes, Maternity Centers & Fertility Clinics and Hospitals, Diagnostic Labs & Service Providers for the Years 2014, 2024 & 2030
    • TABLE 68: China Recent Past, Current & Future Analysis for Preimplantation Genetic Testing by Technology - Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Preimplantation Genetic Testing by Technology - Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 70: China 16-Year Perspective for Preimplantation Genetic Testing by Technology - Percentage Breakdown of Value Sales for Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and Other Technologies for the Years 2014, 2024 & 2030
  • EUROPE
    • Preimplantation Genetic Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Preimplantation Genetic Testing by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Preimplantation Genetic Testing by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 73: Europe 16-Year Perspective for Preimplantation Genetic Testing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Preimplantation Genetic Testing by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Preimplantation Genetic Testing by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 76: Europe 16-Year Perspective for Preimplantation Genetic Testing by Component - Percentage Breakdown of Value Sales for Reagents & Consumables, Instruments and Software & Services for the Years 2014, 2024 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Preimplantation Genetic Testing by End-Use - Research Laboratories & Academic Institutes, Maternity Centers & Fertility Clinics and Hospitals, Diagnostic Labs & Service Providers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Preimplantation Genetic Testing by End-Use - Research Laboratories & Academic Institutes, Maternity Centers & Fertility Clinics and Hospitals, Diagnostic Labs & Service Providers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 79: Europe 16-Year Perspective for Preimplantation Genetic Testing by End-Use - Percentage Breakdown of Value Sales for Research Laboratories & Academic Institutes, Maternity Centers & Fertility Clinics and Hospitals, Diagnostic Labs & Service Providers for the Years 2014, 2024 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Preimplantation Genetic Testing by Technology - Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Preimplantation Genetic Testing by Technology - Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 82: Europe 16-Year Perspective for Preimplantation Genetic Testing by Technology - Percentage Breakdown of Value Sales for Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and Other Technologies for the Years 2014, 2024 & 2030
  • FRANCE
    • Preimplantation Genetic Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 83: France Recent Past, Current & Future Analysis for Preimplantation Genetic Testing by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Preimplantation Genetic Testing by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 85: France 16-Year Perspective for Preimplantation Genetic Testing by Component - Percentage Breakdown of Value Sales for Reagents & Consumables, Instruments and Software & Services for the Years 2014, 2024 & 2030
    • TABLE 86: France Recent Past, Current & Future Analysis for Preimplantation Genetic Testing by End-Use - Research Laboratories & Academic Institutes, Maternity Centers & Fertility Clinics and Hospitals, Diagnostic Labs & Service Providers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 87: France Historic Review for Preimplantation Genetic Testing by End-Use - Research Laboratories & Academic Institutes, Maternity Centers & Fertility Clinics and Hospitals, Diagnostic Labs & Service Providers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 88: France 16-Year Perspective for Preimplantation Genetic Testing by End-Use - Percentage Breakdown of Value Sales for Research Laboratories & Academic Institutes, Maternity Centers & Fertility Clinics and Hospitals, Diagnostic Labs & Service Providers for the Years 2014, 2024 & 2030
    • TABLE 89: France Recent Past, Current & Future Analysis for Preimplantation Genetic Testing by Technology - Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 90: France Historic Review for Preimplantation Genetic Testing by Technology - Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 91: France 16-Year Perspective for Preimplantation Genetic Testing by Technology - Percentage Breakdown of Value Sales for Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and Other Technologies for the Years 2014, 2024 & 2030
  • GERMANY
    • Preimplantation Genetic Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Preimplantation Genetic Testing by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for Preimplantation Genetic Testing by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 94: Germany 16-Year Perspective for Preimplantation Genetic Testing by Component - Percentage Breakdown of Value Sales for Reagents & Consumables, Instruments and Software & Services for the Years 2014, 2024 & 2030
    • TABLE 95: Germany Recent Past, Current & Future Analysis for Preimplantation Genetic Testing by End-Use - Research Laboratories & Academic Institutes, Maternity Centers & Fertility Clinics and Hospitals, Diagnostic Labs & Service Providers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for Preimplantation Genetic Testing by End-Use - Research Laboratories & Academic Institutes, Maternity Centers & Fertility Clinics and Hospitals, Diagnostic Labs & Service Providers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 97: Germany 16-Year Perspective for Preimplantation Genetic Testing by End-Use - Percentage Breakdown of Value Sales for Research Laboratories & Academic Institutes, Maternity Centers & Fertility Clinics and Hospitals, Diagnostic Labs & Service Providers for the Years 2014, 2024 & 2030
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Preimplantation Genetic Testing by Technology - Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Germany Historic Review for Preimplantation Genetic Testing by Technology - Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 100: Germany 16-Year Perspective for Preimplantation Genetic Testing by Technology - Percentage Breakdown of Value Sales for Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and Other Technologies for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 101: Italy Recent Past, Current & Future Analysis for Preimplantation Genetic Testing by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for Preimplantation Genetic Testing by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 103: Italy 16-Year Perspective for Preimplantation Genetic Testing by Component - Percentage Breakdown of Value Sales for Reagents & Consumables, Instruments and Software & Services for the Years 2014, 2024 & 2030
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Preimplantation Genetic Testing by End-Use - Research Laboratories & Academic Institutes, Maternity Centers & Fertility Clinics and Hospitals, Diagnostic Labs & Service Providers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for Preimplantation Genetic Testing by End-Use - Research Laboratories & Academic Institutes, Maternity Centers & Fertility Clinics and Hospitals, Diagnostic Labs & Service Providers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 106: Italy 16-Year Perspective for Preimplantation Genetic Testing by End-Use - Percentage Breakdown of Value Sales for Research Laboratories & Academic Institutes, Maternity Centers & Fertility Clinics and Hospitals, Diagnostic Labs & Service Providers for the Years 2014, 2024 & 2030
    • TABLE 107: Italy Recent Past, Current & Future Analysis for Preimplantation Genetic Testing by Technology - Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Italy Historic Review for Preimplantation Genetic Testing by Technology - Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 109: Italy 16-Year Perspective for Preimplantation Genetic Testing by Technology - Percentage Breakdown of Value Sales for Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and Other Technologies for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Preimplantation Genetic Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 110: UK Recent Past, Current & Future Analysis for Preimplantation Genetic Testing by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for Preimplantation Genetic Testing by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 112: UK 16-Year Perspective for Preimplantation Genetic Testing by Component - Percentage Breakdown of Value Sales for Reagents & Consumables, Instruments and Software & Services for the Years 2014, 2024 & 2030
    • TABLE 113: UK Recent Past, Current & Future Analysis for Preimplantation Genetic Testing by End-Use - Research Laboratories & Academic Institutes, Maternity Centers & Fertility Clinics and Hospitals, Diagnostic Labs & Service Providers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for Preimplantation Genetic Testing by End-Use - Research Laboratories & Academic Institutes, Maternity Centers & Fertility Clinics and Hospitals, Diagnostic Labs & Service Providers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 115: UK 16-Year Perspective for Preimplantation Genetic Testing by End-Use - Percentage Breakdown of Value Sales for Research Laboratories & Academic Institutes, Maternity Centers & Fertility Clinics and Hospitals, Diagnostic Labs & Service Providers for the Years 2014, 2024 & 2030
    • TABLE 116: UK Recent Past, Current & Future Analysis for Preimplantation Genetic Testing by Technology - Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 117: UK Historic Review for Preimplantation Genetic Testing by Technology - Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 118: UK 16-Year Perspective for Preimplantation Genetic Testing by Technology - Percentage Breakdown of Value Sales for Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and Other Technologies for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 119: Rest of Europe Recent Past, Current & Future Analysis for Preimplantation Genetic Testing by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 120: Rest of Europe Historic Review for Preimplantation Genetic Testing by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 121: Rest of Europe 16-Year Perspective for Preimplantation Genetic Testing by Component - Percentage Breakdown of Value Sales for Reagents & Consumables, Instruments and Software & Services for the Years 2014, 2024 & 2030
    • TABLE 122: Rest of Europe Recent Past, Current & Future Analysis for Preimplantation Genetic Testing by End-Use - Research Laboratories & Academic Institutes, Maternity Centers & Fertility Clinics and Hospitals, Diagnostic Labs & Service Providers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 123: Rest of Europe Historic Review for Preimplantation Genetic Testing by End-Use - Research Laboratories & Academic Institutes, Maternity Centers & Fertility Clinics and Hospitals, Diagnostic Labs & Service Providers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 124: Rest of Europe 16-Year Perspective for Preimplantation Genetic Testing by End-Use - Percentage Breakdown of Value Sales for Research Laboratories & Academic Institutes, Maternity Centers & Fertility Clinics and Hospitals, Diagnostic Labs & Service Providers for the Years 2014, 2024 & 2030
    • TABLE 125: Rest of Europe Recent Past, Current & Future Analysis for Preimplantation Genetic Testing by Technology - Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Rest of Europe Historic Review for Preimplantation Genetic Testing by Technology - Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 127: Rest of Europe 16-Year Perspective for Preimplantation Genetic Testing by Technology - Percentage Breakdown of Value Sales for Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and Other Technologies for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Preimplantation Genetic Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 128: Asia-Pacific Recent Past, Current & Future Analysis for Preimplantation Genetic Testing by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Asia-Pacific Historic Review for Preimplantation Genetic Testing by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 130: Asia-Pacific 16-Year Perspective for Preimplantation Genetic Testing by Component - Percentage Breakdown of Value Sales for Reagents & Consumables, Instruments and Software & Services for the Years 2014, 2024 & 2030
    • TABLE 131: Asia-Pacific Recent Past, Current & Future Analysis for Preimplantation Genetic Testing by End-Use - Research Laboratories & Academic Institutes, Maternity Centers & Fertility Clinics and Hospitals, Diagnostic Labs & Service Providers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Asia-Pacific Historic Review for Preimplantation Genetic Testing by End-Use - Research Laboratories & Academic Institutes, Maternity Centers & Fertility Clinics and Hospitals, Diagnostic Labs & Service Providers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 133: Asia-Pacific 16-Year Perspective for Preimplantation Genetic Testing by End-Use - Percentage Breakdown of Value Sales for Research Laboratories & Academic Institutes, Maternity Centers & Fertility Clinics and Hospitals, Diagnostic Labs & Service Providers for the Years 2014, 2024 & 2030
    • TABLE 134: Asia-Pacific Recent Past, Current & Future Analysis for Preimplantation Genetic Testing by Technology - Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Asia-Pacific Historic Review for Preimplantation Genetic Testing by Technology - Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 136: Asia-Pacific 16-Year Perspective for Preimplantation Genetic Testing by Technology - Percentage Breakdown of Value Sales for Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and Other Technologies for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 137: Rest of World Recent Past, Current & Future Analysis for Preimplantation Genetic Testing by Component - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Rest of World Historic Review for Preimplantation Genetic Testing by Component - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 139: Rest of World 16-Year Perspective for Preimplantation Genetic Testing by Component - Percentage Breakdown of Value Sales for Reagents & Consumables, Instruments and Software & Services for the Years 2014, 2024 & 2030
    • TABLE 140: Rest of World Recent Past, Current & Future Analysis for Preimplantation Genetic Testing by End-Use - Research Laboratories & Academic Institutes, Maternity Centers & Fertility Clinics and Hospitals, Diagnostic Labs & Service Providers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Rest of World Historic Review for Preimplantation Genetic Testing by End-Use - Research Laboratories & Academic Institutes, Maternity Centers & Fertility Clinics and Hospitals, Diagnostic Labs & Service Providers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 142: Rest of World 16-Year Perspective for Preimplantation Genetic Testing by End-Use - Percentage Breakdown of Value Sales for Research Laboratories & Academic Institutes, Maternity Centers & Fertility Clinics and Hospitals, Diagnostic Labs & Service Providers for the Years 2014, 2024 & 2030
    • TABLE 143: Rest of World Recent Past, Current & Future Analysis for Preimplantation Genetic Testing by Technology - Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Rest of World Historic Review for Preimplantation Genetic Testing by Technology - Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 145: Rest of World 16-Year Perspective for Preimplantation Genetic Testing by Technology - Percentage Breakdown of Value Sales for Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH) and Other Technologies for the Years 2014, 2024 & 2030

IV. COMPETITION